Evidence map›Paper›PMID 35111949›Full record

ReviewBioengineering & translational medicine2022

Fourth-generation glucose sensors composed of copper nanostructures for diabetes management: A critical review.

Gowhar A Naikoo, Tasbiha Awan, Hiba Salim, Fareeha Arshad, Israr U Hassan, Mona Zamani Pedram, Waqar Ahmed, Hakkim L Faruck, Alaa A A Aljabali, Vijay Mishra and 8 more

Abstract readReview
In one paragraph

Review in Bioengineering & translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Biomaterials for biomarker imaging and detection.Journal of advanced research · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Gowhar A NaikooDepartment of Mathematics and Sciences College of Arts and Applied Sciences, Dhofar University Salalah Oman.ORCID https://orcid.org/0000-0001-9103-5126
Tasbiha AwanDepartment of Mathematics and Sciences College of Arts and Applied Sciences, Dhofar University Salalah Oman.
Hiba SalimDepartment of Mathematics and Sciences College of Arts and Applied Sciences, Dhofar University Salalah Oman.
Fareeha ArshadDepartment of Biochemistry Aligarh Muslim University Aligarh India.
Israr U HassanCollege of Engineering Dhofar University Salalah Oman.
Mona Zamani PedramFaculty of Mechanical Engineering-Energy Division K.N. Toosi University of Technology Tehran Iran.
Waqar AhmedSchool of Mathematics and Physics College of Science, University of Lincoln Lincoln UK.
Hakkim L FaruckThe Hormel Institute University of Minnesota Austin Minnesota USA.
Alaa A A AljabaliDepartmnt of Pharmaceutics and Pharmaceutical Technology Yarmouk University Irbid Jordan.ORCID https://orcid.org/0000-0002-9519-6338
Vijay MishraSchool of Pharmaceutical Sciences Lovely Professional University Phagwara Punjab India.ORCID https://orcid.org/0000-0001-6542-2464
Ángel Serrano-ArocaBiomaterials and Bioengineering Lab Translational Research Centre San Alberto Magno, Catholic University of Valencia San Vicente Mártir Valencia Spain.ORCID https://orcid.org/0000-0002-9953-3848
Rohit GoyalSchool of Pharmaceutical Sciences Shoolini University of Biotechnology and Management Sciences Solan India.
Poonam NegiSchool of Pharmaceutical Sciences Shoolini University of Biotechnology and Management Sciences Solan India.
Martin BirkettDepartment of Mechanical and Construction Engineering Northumbria University Newcastle upon Tyne UK.
Mohamed M NasefDepartment of Pharmacy School of Applied Science, University of Huddersfield UK.ORCID https://orcid.org/0000-0003-4228-7671
Nitin B CharbeDepartment of Pharmaceutical Sciences Rangel College of Pharmacy, Texas A&M University Kingsville Texas USA.
Hamid A BakshiSchool of Pharmacy and Pharmaceutical Science Ulster University Coleraine UK.
Murtaza M TambuwalaSchool of Pharmacy and Pharmaceutical Science Ulster University Coleraine UK.ORCID https://orcid.org/0000-0001-8499-9891

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

More than five decades have been invested in understanding glucose biosensors. Yet, this immensely versatile field has continued to gain attention from the scientific world to better understand and diagnose diabetes. However, such extensive work done to improve glucose sensing devices has still not yielded desirable results. Drawbacks like the necessity of the invasive finger-pricking step and the lack of optimization of diagnostic interventions still need to be considered to improve the testing process of diabetic patients. To upgrade the glucose-sensing devices and reduce the number of intermediary steps during glucose measurement, fourth-generation glucose sensors (FGGS) have been introduced. These sensors, made using robust electrocatalytic copper nanostructures, improve diagnostic efficiency and cost-effectiveness. This review aims to present the essential scientific progress in copper nanostructure-based FGGS in the past 10 years (2010 to present). After a short introduction, we presented the working principles of these sensors. We then highlighted the importance of copper nanostructures as advanced electrode materials to develop reliable real-time FGGS. Finally, we cover the advantages, shortcomings, and prospects for developing highly sensitive, stable, and specific FGGS.

Indexed as

diabetes managementearly detectionelectrode materialshybrid copper nanostructuresnonenzymatic glucose sensors

Identifiers

PMID35111949
PMCPMC8780923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.